Effects of Autologous Conditioned Serum, Autologous Protein Solution, and Triamcinolone on Inflammatory and Catabolic Gene Expression in Equine Cartilage and Synovial Explants Treated With IL-1β in Co-culture.
Authors: Velloso Alvarez Ana, Boone Lindsey H, Pondugula Satyanarayana R, Caldwell Fred, Wooldridge Anne A
Journal: Frontiers in veterinary science
Summary
# Editorial Summary Autologous conditioned serum (ACS) and autologous protein solution (APS) represent promising alternatives to corticosteroid treatment for equine osteoarthritis, yet evidence comparing their effectiveness at the cellular level remains limited. Researchers from the University of Georgia cultured cartilage and synovial tissue explants from equine stifles in co-culture and stimulated them with interleukin-1 beta (IL-1β)—a model that reproduces the inflammatory cascade seen in naturally occurring joint disease—before treating them with either 25% or 50% concentrations of ACS, APS, or triamcinolone (TA). At the 50% concentration, both ACS and APS suppressed IL-1β expression in cartilage significantly more effectively than triamcinolone, whilst APS uniquely downregulated MMP-1 expression in the synovial membrane; notably, APS reduced prostaglandin E2 (PGE2) concentrations in the culture medium by 13.7-fold compared with only 4.13-fold for ACS and just 2.3-fold for TA. Both biological therapies also demonstrated trends towards upregulating protective factors including IL-10 and cartilage matrix components (type II collagen and aggrecan), suggesting a disease-modifying rather than purely anti-inflammatory mechanism. For practitioners managing equine OA, these findings indicate that ACS and APS may offer substantive advantages over conventional corticosteroid injection, particularly in their capacity to reduce catabolic signalling whilst promoting tissue-protective responses.
Read the full abstract on PubMed
Practical Takeaways
- •ACS and APS may provide superior anti-inflammatory effects compared to intra-articular triamcinolone for managing osteoarthritis at the cellular level
- •The 50% concentration of ACS/APS appears optimal for suppressing inflammatory cytokines and catabolic enzymes in joint tissues
- •Consider autologous therapies as potential disease-modifying treatments that may better preserve cartilage integrity than corticosteroids alone
Key Findings
- •APS and ACS at 50% concentration downregulated IL-1β expression in cartilage more effectively than triamcinolone (p=0.001 and p=0.0004)
- •APS reduced PGE2 media concentrations by 13.7-fold (p=0.0001) and ACS by 4.13-fold (p=0.024), compared to triamcinolone's non-significant 2.3-fold reduction (p=0.406)
- •APS downregulated MMP-1 expression in synovial membrane (p=0.025), suggesting reduced cartilage breakdown
- •ACS and APS showed trends toward upregulating protective factors IL-10, type II collagen, and aggrecan in inflamed joint tissues